These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21747279)

  • 1. Oxidative stress in heart failure: what are we missing?
    Sawyer DB
    Am J Med Sci; 2011 Aug; 342(2):120-4. PubMed ID: 21747279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and heart failure.
    Tsutsui H; Kinugawa S; Matsushima S
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2181-90. PubMed ID: 21949114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
    Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
    Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of reactive oxygen species in myocardial remodeling.
    Zhang M; Shah AM
    Curr Heart Fail Rep; 2007 Mar; 4(1):26-30. PubMed ID: 17386182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.
    Dey S; DeMazumder D; Sidor A; Foster DB; O'Rourke B
    Circ Res; 2018 Jul; 123(3):356-371. PubMed ID: 29898892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nitric oxide pathway and oxidative stress in heart failure.
    Searles CD
    Congest Heart Fail; 2002; 8(3):142-7, 155. PubMed ID: 12045382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating oxidative stress in heart failure: past, present and future.
    van der Pol A; van Gilst WH; Voors AA; van der Meer P
    Eur J Heart Fail; 2019 Apr; 21(4):425-435. PubMed ID: 30338885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.
    McCarty MF
    Med Hypotheses; 2010 Aug; 75(2):141-7. PubMed ID: 20083360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of oxidative stress in heart failure].
    Gál R; Halmosi R
    Orv Hetil; 2015 Nov; 156(47):1916-20. PubMed ID: 26568107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-sensitive mechanisms underlying vascular dysfunction in heart failure.
    Konradi J; Mollenhauer M; Baldus S; Klinke A
    Free Radic Res; 2015 Jun; 49(6):721-42. PubMed ID: 25788126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echinacoside reverses myocardial remodeling and improves heart function via regulating SIRT1/FOXO3a/MnSOD axis in HF rats induced by isoproterenol.
    Ni Y; Deng J; Liu X; Li Q; Zhang J; Bai H; Zhang J
    J Cell Mol Med; 2021 Jan; 25(1):203-216. PubMed ID: 33314649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies.
    Aimo A; Castiglione V; Borrelli C; Saccaro LF; Franzini M; Masi S; Emdin M; Giannoni A
    Eur J Prev Cardiol; 2020 Mar; 27(5):494-510. PubMed ID: 31412712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and myocardial remodeling in chronic mitral regurgitation.
    Gladden JD; Ahmed MI; Litovsky SH; Schiros CG; Lloyd SG; Gupta H; Denney TS; Darley-Usmar V; McGiffin DC; Dell'Italia LJ
    Am J Med Sci; 2011 Aug; 342(2):114-9. PubMed ID: 21795957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant treatment for heart failure: friend or foe?
    Thomson MJ; Frenneaux MP; Kaski JC
    QJM; 2009 May; 102(5):305-10. PubMed ID: 19095676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between angiogenesis and abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure, and improvement by puerarin.
    He H; Shi M; Yang J; Zeng X; Qiao H; Wu L; Li L
    Phytother Res; 2008 Jul; 22(7):948-56. PubMed ID: 18389490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.
    Bhimaraj A; Tang WH
    Heart Fail Clin; 2012 Jan; 8(1):101-11. PubMed ID: 22108730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure.
    Terentyev D; Györke I; Belevych AE; Terentyeva R; Sridhar A; Nishijima Y; de Blanco EC; Khanna S; Sen CK; Cardounel AJ; Carnes CA; Györke S
    Circ Res; 2008 Dec; 103(12):1466-72. PubMed ID: 19008475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.
    Xu Q; Dalic A; Fang L; Kiriazis H; Ritchie RH; Sim K; Gao XM; Drummond G; Sarwar M; Zhang YY; Dart AM; Du XJ
    Br J Pharmacol; 2011 Mar; 162(5):1012-28. PubMed ID: 20955367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxidative stress in transition of hypertrophy to heart failure.
    Dhalla AK; Hill MF; Singal PK
    J Am Coll Cardiol; 1996 Aug; 28(2):506-14. PubMed ID: 8800132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.
    Seddon M; Looi YH; Shah AM
    Heart; 2007 Aug; 93(8):903-7. PubMed ID: 16670100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.